With pharmacy benefit managers (PBMs) guarding the secrecy of their price negotiations more than HBO is guarding the ending of its Game of Thrones, PBMs have become one of the "most confounding, gnarled riddles in health care," U.S. Sen Ron Wyden (D-Ore.) said in his opening remarks Tuesday at the third in a series of Senate Finance Committee hearings on prescription drug prices.